Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 2 52-2, 2002, Pages

  Johnson, Wendy ^a   Nohria, Anju ^a   Garrett, Leslie ^a   Fang, James C ^a   Igo, James ^a   Katai, Miyuki ^a   Ganz, Peter ^a   Creager, Mark A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Hypoxia; Pulmonary hypertension; Vascular resistance; Vasodilation

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPOXIA; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MALE; NORMAL HUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEPTOR BLOCKING; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0036073733     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00099.2001     Document Type: Article

References (73)

1. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance
2. Central and regional hemodynamic effects during infusion of Big endothelin-1 in healthy humans
3. Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans
4. Cloning and expression of a cDNA encoding an endothelin receptor
5. Intermittent hypoxia increases lobar hypoxic pulmonary vasoconstriction
6. Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ-123, in the human forearm
7. Hypoxic pulmonary vasoconstriction in the human lung: Effect of repeated hypoxic challenges during anesthesia
8. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans
9. A receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation
10. Characterisation of the endothelin receptor mediating contraction of human pulmonary artery using BQ123 and Ro 46-2005
11. Endothelin-1 in the lungs of patients with pulmonary hypertension
12. Role of endothelin in the increased vascular tone of patients with essential hypertension
13. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study
14. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats
15. Endothelin is a potent long-lasting vasoconstrictor in men
16. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure
17. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans
18. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat
19. Pulmonary vasoregulation by endothelin in conscious dogs after left lung transplantation
20. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension
21. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats
22. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat
23. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo
24. Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension?
25. Endothelin-1 is elevated in monocrotaline pulmonary hypertension
26. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation
27. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
28. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure
29. Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn piglet
30. Efficacy of CI-1020, an endothelin-A receptor antagonist, in hypoxic pulmonary hypertension
31. Endothelin 1: Mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells
32. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans
33. B receptors cause vasoconstriction of human resistance and capacitance vessels in vivo
34. Contribution of endogenous generation of endothelin-1 to basal vascular tone
35. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells
36. Specific receptor for endothelin in cultured rat cardiocytes
37. The endothelin antagonist bosentan: Hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs
38. B receptor antagonist BQ-788 reduces the pulmonary vasodilator effect of endothelin-1 during acute hypoxia in pigs
39. A receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo
40. A receptor
41. A receptor
42. A receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats
43. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells
44. Cardiopulmonary effects of endothelin-1 in man
45. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells
46. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia
47. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia
48. Endothelin produces pulmonary vasoconstriction and systemic vasodilation
49. Regulation of endothelin-1 synthesis in human pulmonary arterial smooth muscle cells. Effects of transforming growth factor-beta and hypoxia
50. On pulmonary vascular resistance: The need for more precise definition
51. Plasma endothelin in chronic heart failure
52. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse
53. The influence of short periods of induced hypoxia upon pulmonary artery pressures in man
54. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels
55. Endothelin receptor antagonists in a beagle model of pulmonary hypertension: Contribution to possible potential therapy?
56. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat
57. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
58. Long-lasting coronary vasoconstrictor effects and myocardial uptake of endothelin-1 in humans
59. Potentiation of lobar hypoxic pulmonary vasoconstriction by intermittent hypoxia in dogs
60. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart
61. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
62. Exaggerated endothelin release in high-altitude pulmonary edema
63. A receptor-mediated inhibition of KATP channel
64. Elevated endothelin-1 in heart failure and loss of normal response to postural change
65. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men
66. Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs
67. Potentiation of pulmonary vasoconstrictor response with repeated intermittent hypoxia
68. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
69. Observations on the pulmonary arterial blood pressure in the cat
70. Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan
71. Nonpeptide endothelin receptor antagonists. VIII. Attentuation of acute hypoxia-induced pulmonary hypertension in the dog
72. Endothelin-1 does not mediate acute hypoxic pulmonary vasoconstriction in the intact newborn lamb
73. A receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells